Urol Pract. 2025 Jan 10:101097UPJ0000000000000760. doi: 10.1097/UPJ.0000000000000760. Online ahead of print.
ABSTRACT
INTRODUCTION: Clinic no-shows result in misallocation of health care resources and decreased access to care. There is minimal published data examining factors associated with no-shows for ambulatory urology visits. We analyzed data from a large cohort of outpatient encounters at a tertiary health system to identify factors that increase the likelihood of ambulatory urology no-show.
METHODS: Data were available from scheduled ambulatory urology appointments at 18 clinics in an academic, tertiary health system between January 1, 2018, and June 30, 2023. A control group of completed appointments and a study group of no-show appointments were used for comparative statistics. χ2 and t tests were used to make comparisons. The false discovery rate-adjusted P value was calculated using Bonferroni method.
RESULTS: Data were available from a total of 990,749 appointments. A total of 187,036 appointments from 10 clinics met inclusion and exclusion criteria, among which 177,718 (95%) were completed appointments and 9318 (5%) were patient no-shows. Patients who no-showed were younger (58 years vs 62 years; P < .01) and Black (odds ratio [OR] 3.74). No-shows were more common if the visit was virtual (OR 1.50) or follow-up (OR 1.50). Patients referred from the emergency department were more likely to no-show (OR 1.50). Of the 26 urologic diagnoses examined, testis cancer (OR 2.58) and orchitis (OR 2.49) appointments were more likely to no-show.
CONCLUSIONS: We analyzed ambulatory urology appointments within our hospital enterprise and found factors associated with a higher rate of no-show. These data may be helpful to identify patients at risk of no-show and to implement tailored strategies to enhance clinic attendance.
PMID:39903836 | DOI:10.1097/UPJ.0000000000000760
